scispace - formally typeset
A

Alison J. Sinclair

Researcher at University of Sussex

Publications -  75
Citations -  3675

Alison J. Sinclair is an academic researcher from University of Sussex. The author has contributed to research in topics: Epstein–Barr virus & Lytic cycle. The author has an hindex of 32, co-authored 75 publications receiving 3518 citations. Previous affiliations of Alison J. Sinclair include McGill University Health Centre & Imperial College London.

Papers
More filters
Journal ArticleDOI

Synthetic peptide homologous to beta protein from Alzheimer disease forms amyloid-like fibrils in vitro.

TL;DR: These findings on these homologous synthetic assemblies help to define the specific sequence that is required to form Alzheimer-type amyloid fibrils, thus providing an in vitro model of age-related cerebral amyloidsogenesis.
Journal ArticleDOI

A thyroid-specific nuclear protein essential for tissue-specific expression of the thyroglobulin promoter.

TL;DR: The results suggest that the tissue‐specific expression of the thyroglobulin genes is mediated, at least in part, by the presence of a transcription factor exclusively in thyroid cells.
Journal ArticleDOI

EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.

TL;DR: The progression of resting B lymphocytes into the G1 phase of the cell cycle can be reconstituted in the absence of virus by the cooperation of two of the six viral genes required for immortalization.
Journal ArticleDOI

Systematic Review and Meta-Analysis of a Urine-Based Pneumococcal Antigen Test for Diagnosis of Community-Acquired Pneumonia Caused by Streptococcus pneumoniae

TL;DR: The higher pooled sensitivity (compared to culture) and high specificity of BinaxNOW-SP suggest it would be a useful addition to the diagnostic workup for community-acquired pneumonia.
Journal ArticleDOI

Pathways of activation of the Epstein-Barr virus productive cycle.

TL;DR: The results indicate some likely pathways of activation of Epstein-Barr virus productive cycle gene expression and site-directed mutagenesis suggests that two binding sites for BZLF1 within the promoter contribute to the transactivation by BZlF1.